IPOs

Leading cybersecurity brand McAfee sets terms for $759 million IPO

McAfee, a leading provider of antivirus and endpoint security software, announced terms for its IPO on Tuesday.

The San Jose, CA-based company plans to raise $759 million by offering 37 million shares (21% secondary/synthetic) at a price range of $19 to $22. At the midpoint of the proposed range, McAfee would command a fully diluted market value of $9.6 billion. The company plans to offer a quarterly dividend, with an annual dividend yield of 1.7% at the midpoint of the price range. 

McAfee is a leading brand in cybersecurity used by consumers, enterprises, and governments. Its consumer-focused products protected over 600 million devices as of June 27, 2020.

McAfee was founded in 1987 and booked $2.7 billion in sales for the 12 months ended June 27, 2020. It plans to list on the Nasdaq under the symbol MCFE. Morgan Stanley, Goldman Sachs, TPG Capital BD, BofA Securities, Citi, RBC Capital Markets, Deutsche Bank, UBS Investment Bank, HSBC and Mizuho Securities are the joint bookrunners on the deal. It is expected to price the week of October 19, 2020.

The article Leading cybersecurity brand McAfee sets terms for $759 million IPO originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.

Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital's Renaissance IPO ETF (symbol: IPO), Renaissance International ETF (symbol: IPOS), or separately managed institutional accounts may have investments in securities of companies mentioned.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest IPOs Videos

    Renaissance Capital

    Renaissance Capital is the global leader in providing pre-IPO institutional research and management of IPO-focused investment products.

    Learn More